Cardiovascular Archives | Report Store | Pharma intelligence

show blocks helper

Filter reports

Sort by Default Order
- Default Order
- Name
- Price
- Date
- Popularity

Click to order products descending

Display 15 Products per page

Diagnostic and Guided Interventional Cardiology Products Market
$4,750.00
This comprehensive medical market and technology report provides an overview and in-depth market analysis of diagnostic and guided interventional cardiology devices (specifically, transcatheter angiography, guidewire-based intravascular stenosis assessment, intracardiac echocardiography (ICE), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted surgical systems) used in the diagnosis of cardiovascular diseases (CVDs) and guidance of minimally invasive therapies.
July 31, 2017
Select options
Minimally Invasive Weight Loss (Bariatric) Devices Market
$4,750.00
The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million. The combined market for inhalation drug delivery devices totaled nearly $11.7bn in 2016, and is expected to climb at a rate of 1.2% over the forecast period. Generic erosion will be a key factor in limiting growth in the overall market; however, increasing disease prevalence and the introduction of novel products such as triple combination therapies will offset declines. The US accounts for nearly two-thirds of the overall inhalation drug delivery devices market, and is expected to experience the most growth over the forecast period as its population increases and ages.
July 28, 2017
Select options
Inhalation Drug Delivery Devices Market
$4,750.00
The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million. The combined market for inhalation drug delivery devices totaled nearly $11.7bn in 2016, and is expected to climb at a rate of 1.2% over the forecast period. Generic erosion will be a key factor in limiting growth in the overall market; however, increasing disease prevalence and the introduction of novel products such as triple combination therapies will offset declines. The US accounts for nearly two-thirds of the overall inhalation drug delivery devices market, and is expected to experience the most growth over the forecast period as its population increases and ages.
July 19, 2017
Select options
Heart Valve Repair and Replacement Devices Market
$4,750.00
The global market for heart valve repair and replacement devices is being driven by the increasing burden of heart valve disease, which left untreated can lead to severe and life-threatening cardiovascular diseases. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the worldwide heart valve repair and replacement devices market, which includes percutaneous balloon valvuloplasty, heart valve surgery, transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve regurgitation therapy (TMVrep). Global heart valve repair and replacement device sales are projected to expand at a compound annual growth rate (CAGR) of 10.9% during 2016-21, increasing from approximately $4,834.7m in 2016 to an estimated $8,094.4m in 2021. Countries/regions covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World segment (which combines estimated sales data for all other countries).
July 1, 2017
Select options
United Kingdom, Surgical Procedure Volumes
$4,850.00
This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union member state of the U.K.
September 22, 2016
Select options
France, Disease Incidence and Prevalence
$4,850.00
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry.

Select options
U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products
$4,750.00
Diagnostic interventional cardiology procedures covered by the scope of this report include electrocardiography (ECG); non-invasive imaging systems including computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, ultrasound, and X-ray

Select options
U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies
$4,750.00
This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities in the U.S. interventional peripheral vascular disease management arena.

Select options
U.S. Markets for Heart Valve Disorder Management Products
$4,750.00
This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.

Select options
U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products
$3,750.00
U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products, March 2015

Select options
International Markets for Vascular Access Site Closure Devices
$4,750.00
Cardiovascular diseases (CVDs) are the leading causes of death throughout the world. Based on Datamonitor Healthcare estimates, approximately 500 million CVD-related cases occurred in the United States (U.S.), China, Japan, and the five major countries of Europe (France, Germany, Italy, Spain, and the United Kingdom [U.K.]).
June 30, 2016
Select options
U.S. Markets for Interventional Cardiology Products, April 2016
$4,750.00
In the United States (U.S.), approximately 85.6 million adults have at least one type of cardiovascular disease (CVD), a broad group of disorders that affect the heart and circulatory system. Cardiovascular disease in all its forms accounts for more deaths than any other major cause in the U.S.
April 1, 2016
Select options
Asia-Pacific Disease Incidence and Prevalence
$5,250.00
The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.
January 1, 2016
Select options
U.S. Patient Monitoring Devices Market, November 2015
$5,250.00
This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market.
November 2, 2015
Select options
U.S. Surgical Procedure Volumes
$4,750.00
This report presents the most common surgical procedures performed in the United States (U.S.) as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends.
November 1, 2015
Select options

Cardiovascular

Cardiovascular

Diagnostic and Guided Interventional Cardiology Products Market

Minimally Invasive Weight Loss (Bariatric) Devices Market

Inhalation Drug Delivery Devices Market

Heart Valve Repair and Replacement Devices Market

United Kingdom, Surgical Procedure Volumes

France, Disease Incidence and Prevalence

U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products

U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies

U.S. Markets for Heart Valve Disorder Management Products

U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products

International Markets for Vascular Access Site Closure Devices

U.S. Markets for Interventional Cardiology Products, April 2016

Asia-Pacific Disease Incidence and Prevalence

U.S. Patient Monitoring Devices Market, November 2015

U.S. Surgical Procedure Volumes